Esmolol formulation
An aqueous, sterile pharmaceutical composition suitable for parenteral administration for the treatment of cardiac conditions, comprising methyl-3-[4-(2-hydroxy-3-isopropylamino)propoxy]phenylpropionate hydrochloride (esmolol hydrochloride), a buffering agent and an osmotic-adjusting agent, as well as a method for its manufacture, are disclosed.
Baxter International Inc.
A A A A A A A A A A A A
A61K A61K A61P A61K A61K A61K A61P A61P A61P A61K A61P A61K
inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional
Jie Satish K. George
Liu Pejaver Owoo